Department of Plant Biology and Pathology, SEBS, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.
J Ethnopharmacol. 2012 Jul 13;142(2):456-61. doi: 10.1016/j.jep.2012.05.017. Epub 2012 May 15.
The objective of this study was to identify the antiplasmodial constituents from the bark of Cornus florida L., a plant traditionally used in North America for the treatment of malaria.
Dried and powdered bark was extracted with 95% ethanol. The resultant extract was subjected to in vitro antiplasmodial-guided fractionation against Plasmodium falciparum (D10 strain). Antiplasmodial IC(50) values were calculated for pure compounds. Compounds were also assayed against Leishmania tarentolae, and rat skeletal myoblast L6 cells to assess antileishmanial activity and cytotoxicity, respectively.
Antiplasmodial-guided fractionation afforded 8 compounds: betulinic acid (1), ursolic acid (2), β-sitosterol (3), ergosta-4,6,8,22-tetraene-3-one (4), 3β-O-acetyl betulinic acid (5), 3-epideoxyflindissol (6), 3β-O-cis-coumaroyl betulinic acid (7), 3β-O-trans-coumaroyl betulinic acid (8), of which, (6) is for the first time here isolated from a natural product and (4), (7) and (8) are reported for the first time from this genus. In vitro IC(50) values against P. falciparum for (4) (61.0 μM) (6) (128.0 μM), (7) (10.4 μM), (8) (15.3 μM) are reported for the first time. Antileishmanial IC(50) values are reported here for the first time for (4) (11.5 μM), (6) (1.8 μM), (7) (8.3 μM) and (8) (2.2 μM). Cytotoxicity against L6 cells is reported for all compounds.
The compounds isolated in this study, while displaying moderate in vitro antiplasmodial activity, do not fully support the historical importance of C. florida as an antimalarial remedy in North America. The traditional remedy may exert its well documented effects by mechanisms unrelated to direct antiplasmodial action. While not traditionally used to treat Leishmania, this work shows that several constituents of C. florida possess promising in vitro antileishmanial activity.
本研究的目的是从传统上用于北美的治疗疟疾的山茱萸树皮中鉴定出抗疟成分。
干燥的粉状树皮用 95%乙醇提取。将所得提取物进行抗疟导向分离,对抗恶性疟原虫(D10 株)。对纯化合物计算抗疟 IC 50 值。还对利什曼原虫和大鼠骨骼肌成肌细胞 L6 细胞进行了化合物的抗利什曼原虫活性和细胞毒性测定。
抗疟导向分离得到 8 种化合物:桦木酸(1)、熊果酸(2)、β-谷甾醇(3)、麦角甾-4,6,8,22-四烯-3-酮(4)、3β-O-乙酰桦木酸(5)、3-去氧弗林迪斯索尔(6)、3β-O-顺式-香豆酰桦木酸(7)、3β-O-反式-香豆酰桦木酸(8),其中(6)为首次从天然产物中分离得到,(4)、(7)和(8)为首次从该属中分离得到。体外对恶性疟原虫的 IC 50 值为(4)(61.0 μM)、(6)(128.0 μM)、(7)(10.4 μM)、(8)(15.3 μM),这是首次报道。首次报道了(4)(11.5 μM)、(6)(1.8 μM)、(7)(8.3 μM)和(8)(2.2 μM)对利什曼原虫的抗利什曼原虫活性。所有化合物对 L6 细胞均显示出细胞毒性。
本研究分离得到的化合物虽然具有中等体外抗疟活性,但不完全支持山茱萸在北美的传统抗疟功效。传统疗法可能通过与直接抗疟作用无关的机制发挥其有充分记录的作用。虽然山茱萸传统上不用于治疗利什曼原虫,但本工作表明山茱萸的几种成分具有有希望的体外抗利什曼原虫活性。